HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 58 filers reported holding HILLEVAX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 558,923 | $7,517,514 | 9.98% |
| Frazier Life Sciences Management, L.P. | 9,781,472 | $131,560,798 | 8.74% |
| Samsara BioCapital, LLC | 799,274 | $10,750,235 | 3.29% |
| VR Adviser, LLC | 2,037,313 | $27,401,860 | 2.88% |
| StepStone Group LP | 826,567 | $11,117,326 | 2.48% |
| ACUTA CAPITAL PARTNERS, LLC | 270,319 | $3,635,791 | 2.44% |
| Deep Track Capital, LP | 2,900,000 | $39,005,000 | 1.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,004,231 | $53,856,907 | 1.19% |
| Carlyle Group Inc. | 1,838,486 | $24,690,867 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $1,479,500 | 0.62% |